Supplementary Table S1 presents the results in detail. The GSEA-enriched pathways mainly participated in allograft rejection, asthma, spinal cord injury, reactome neutrophil degranulation, PID ap1 pathway, and pancreatic adenocarcinoma pathway (Figure 5 and Supplementary Table S1). The gene discussed is MTA2; the disease is asthma.